Lung Cancer Awareness Month: Early Detection, Better Support – Perspectives from Research and Practice

Jasmine Gehrig

Therapeutic Area Lead Lung Cancer


«I never fought against fate, I didn’t ask why, I just wanted to know what to do next.» Marc lives with lung cancer and his attitude encourages others affected by the disease. Despite major medical advances, lung cancer remains one of the deadliest forms of cancer worldwide.1 At AstraZeneca, we are pursuing the goal of doubling the survival rate and eliminating lung cancer as a cause of death in the long term. Early detection and a national screening programme are key to this. That is why, during Lung Cancer Awareness Month in November, we want to raise awareness that early diagnosis can save lives.


In Switzerland, around 4’900 people are diagnosed with lung cancer every year, and around 3’300 die as a result of the disease.2 Approximately 80 to 90 per cent of deaths are linked to smoking.2 However, non-smokers can also develop the disease – for example, through passive smoking, environmental pollutants or genetic mutations. Almost all those affected are over 50 years of age at the time of diagnosis, and only around 30 per cent of cases are detected at an early stage.3 This is often because lung cancer only shows symptoms at a late stage.

Lung cancer also carries a strong stigma. Many sufferers experience prejudice, which puts additional strain on their situation. This can also lead to symptoms being diagnosed too late. Yet the chances of recovery increase significantly when lung cancer is detected early.


Why early detection can save lives

Low-dose computed tomography (CT) can be used to detect lung cancer in its early stages. Some countries already offer quality-assured early detection programmes for people at risk. In Switzerland, initial pilot projects are showing positive results. Unfortunately, however, there is still no comprehensive national screening programme.

Early detection means a significantly higher chance of survival and a better quality of life.


We urgently need a national lung cancer screening programme to detect the disease earlier – and better psychosocial support for those affected.

Michael Emmenegger-Müller, President of «Living with Lung Cancer»

👉 Read the full interview.


Barbara, a lung cancer survivor, never smoked but was nevertheless severely affected by the stigma.


Therapy and treatment – progress that gives hope

Thanks to new therapies, patients can now live longer and better than ever before. Chemotherapy, immunotherapy and targeted drugs are becoming increasingly precise – often with fewer side effects. 

Prof. Sacha Rothschild explains the latest developments in an interview entitled «New hope for patients with small cell lung cancer». He points out that lung cancer can be roughly divided into two main groups: non-small cell lung cancer, which affects around 80% of all patients, usually grows more slowly and offers more therapeutic options than small cell lung cancer. It is more aggressive, spreads more quickly, but responds well to modern combination treatments.


It’s not just about prolonging life, but also about making that time as pleasant as possible – with less breathlessness, less pain and a better quality of life.

Prof. Sacha Rothschild, Chief Physician of Oncology and Haematology at Baden Cantonal Hospital

Ambition: Eliminating lung cancer as a cause of death

We have a clear ambition: by 2030, we want to double the survival rate of lung cancer patients. With the help of artificial intelligence and precise diagnostics, tumours should also be detected earlier and therapies tailored more individually.

As a core partner of the global Lung Ambition Alliance, we work with professional societies, researchers and patient groups in over 50 countries to accelerate innovation and take a holistic approach to care.


Outlook – working together to raise awareness

The more people talk about lung cancer, the greater the chance of early detection. That is why Lung Cancer Awareness Month in November is all about education and early detection. We are committed to providing better information, destigmatisation, access to diagnostics, and new therapies and research that give hope.

Every story is different – but each one shows that early diagnosis, knowledge and modern medicine can improve lives. That is what we are committed to. 

📎 Further information

Lung cancer – information from the Swiss Lung Association

Explanatory video on lung cancer from the Swiss Lung Association

 



What is Lung Cancer?2

Lung cancer is a malignant tumour in the lungs in which cells multiply uncontrollably and can invade healthy tissue. These tumour cells can spread throughout the body via the lymphatic and bloodstream systems and form metastases.

Typical Symptoms:2

Persistent cough

Shortness of breath

Chest pain

Repeated respiratory infections

Risk Factors:2

Smoking and passive smoking

Radon (a natural noble gas that can occur in buildings)

Environmental pollutants

Genetic modifications

 



Living with lung cancer – experiences that give courage

When Marc was diagnosed with lung cancer, he wanted to know above all else what would happen next. He faced the disease with clear decisions and structure – even when it returned. After successful chemotherapy, he took the step of participating in a clinical trial testing new treatment approaches and found new hope.

👉 You can read more about his experience on the website «Leben mit Krebs».

Ernst knew the risks: «I smoked for 52 years – fully aware that I could develop lung cancer later in life.» He had regular check-ups – and it was precisely this routine that led to his early diagnosis. Today he is healthy and shares his experiences with other patients.

👉 Read more about Ernst’s experiences in Gesundheitsratgeber.

Barbara felt that something was wrong while jogging. She had practically never smoked and experienced the stigma clearly: «Many people thought I was a smoker and therefore responsible for my own condition. My impression is that there is more sympathy for other types of cancer.» Although it was a difficult form of cancer, her doctor gave her hope. Today she is cancer-free and emphasises the importance of early diagnosis. 

👉 She recounts her experience in the video.



Interview with Michael Emmenegger-Müller, President Living with Lung Cancer Association 


In this interview, Michael Emmenegger-Müller discusses developments, myths and progress.

How has the situation for lung cancer patients changed since the association was founded – and what has been achieved since then?

A lot has happened in recent years: lung cancer now receives much more attention – both from the public and from experts. Great progress has been made in treatments, particularly through immunotherapy and targeted drugs.

As an association, we have succeeded in building a strong community of patients who support each other. In addition, we have been able to break down prejudices and promote understanding for patients through greater education. Finally, we are increasingly represented in political and health policy discussions.

 

What concerns or questions do you encounter most frequently when talking to patients and their families?

Many affected individuals want to know what treatment options are available and how they can access specialist centres. Stigmatisation is a major issue – many affected individuals are confronted with the assumption that they are ‘to blame’ for their condition.

Often, it is also about dealing with family, especially children, as well as emotional stress and the search for psychosocial support. Last but not least, many need guidance in the complex healthcare system.

 

Where do you currently see the greatest progress in treatment, and where is there still room for improvement, for example in terms of access or care?

We are seeing enormous progress in personalised medicine: molecular tests enable individually tailored therapies, and immunotherapy has significantly improved the survival rates of many patients. In addition, interdisciplinary treatments in specialised centres offer better care.

However, there is still room for improvement in terms of access – modern therapies are not equally available everywhere. Switzerland also lacks a national screening programme for early detection. In addition, we would like to see better care for rare mutations and more psychosocial support.

 

What myths or misconceptions about lung cancer would you like to dispel?

One of the biggest misconceptions is that lung cancer only affects smokers – this is not true. The assumption that lung cancer is always fatal is also incorrect: today, there is real hope. And the statement that «those affected are to blame» is not only stigmatising, but also hurtful. Lung cancer deserves the same attention and empathy as any other type of cancer.

 

What are your hopes for the future of research, politics, or other players in the healthcare system? 

We urgently need comprehensive national lung cancer screening to detect the disease earlier. Equally important is more research into quality of life and rare mutations.

Patients should be more involved in studies and care processes.

And last but not least, we would like to see education, the media and politics continue to contribute to destigmatisation – so that everyone has the same chance of receiving the best possible treatment.

Because every life counts. Even with lung cancer.




Subject:


References

1 Lung cancer. (2023). Retrieved 2 September 2025, from https://www.who.int/news-room/fact-sheets/detail/lung-cancer

2 Krebsliga, Oktober 2025

3 Cancer Research UK. Incidence by Stage. Available at: https://crukcancerintelligence.shinyapps.io /EarlyDiagnosis/_w_84b6f950752641d9b8791d785490535c/?Tab=incByStage (Accessed October 2025)